These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33622113)

  • 1. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States.
    Hanna ML; Singer D; Valdecantos WC
    Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database.
    Wang HM; Xu JM; Jin HZ
    Am J Clin Dermatol; 2023 Nov; 24(6):991-1002. PubMed ID: 37386353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study.
    Frysz M; Patel S; Li MOY; Griffiths CEM; Warren RB; Ashcroft DM
    Br J Dermatol; 2024 Sep; 191(4):529-538. PubMed ID: 38775029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database.
    Okubo Y; Kotowsky N; Gao R; Saito K; Morita A
    J Dermatol; 2021 Nov; 48(11):1675-1687. PubMed ID: 34390028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database.
    Morita A; Kotowsky N; Gao R; Shimizu R; Okubo Y
    J Dermatol; 2021 Oct; 48(10):1463-1473. PubMed ID: 34212422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
    Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
    Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study.
    Löfvendahl S; Norlin JM; Schmitt-Egenolf M
    Psoriasis (Auckl); 2022; 12():89-98. PubMed ID: 35548662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of smoking cessation on psoriasis vulgaris, palmoplantar pustulosis and generalized pustular psoriasis.
    Kim SR; Choi YG; Jo SJ
    Br J Dermatol; 2024 Jul; 191(2):225-232. PubMed ID: 38534203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic differences between pustular psoriasis subtypes.
    Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
    J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
    Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
    J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A narrative review of the socioeconomic burden associated with generalised pustular psoriasis.
    Zimmermann TM; Hofmann P; Chiu GR
    Exp Dermatol; 2023 Aug; 32(8):1219-1226. PubMed ID: 37309747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of sarcoidosis in a commercially-insured population in the United States.
    Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ
    J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    PLoS One; 2020; 15(5):e0232738. PubMed ID: 32442204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States.
    Hanna ML; Singer D; Bender SD; Valdecantos WC; Wu JJ
    Curr Med Res Opin; 2021 Oct; 37(10):1697-1703. PubMed ID: 34289766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study.
    Brunasso AM; Puntoni M; Aberer W; Delfino C; Fancelli L; Massone C
    Br J Dermatol; 2013 Jun; 168(6):1243-51. PubMed ID: 23301847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence.
    Bhutani T; Farberg AS
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):341-360. PubMed ID: 38363460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study.
    Gisondi P; Bellinato F; Girolomoni G
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity.
    Murage MJ; Anderson A; Oliveria SA; Casso D; Ojeh CK; Muram TM; Merola JF; Araujo AB
    J Med Econ; 2018 Aug; 21(8):745-754. PubMed ID: 29718756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.